Neurotoxins from invertebrates as anticonvulsants: From basic research to therapeutic application

Pharmacology and Therapeutics

Volumn 114, Issue 2, 2007, Pages 171-183

  Mortari, Márcia Renata ^a   Cunha, Alexandra Olimpio Siqueira ^a   Ferreira, Luzitano Brandão ^a   dos Santos, Wagner Ferreira ^a  

^a Neurobiology and Venoms Laboratory   (Brazil)

Author keywords

Anticonvulsants; GABA; Glutamate; Invertebrate venoms; Peptides; Polyamine toxins

Indexed keywords

1 N ACETYLSPERMINE; 3,3 BIS(3 FLUOROPHENYL) N METHYLPROPYLAMINE; ANTICONVULSIVE AGENT; ARGIOTOXIN 636; CL19 TOXIN; CONANTOKIN G; CONANTOKIN L; CONANTOKIN R; CONANTOKIN T; CONTULAKIN G; DIZOCILPINE; FRPBAII TOXIN; IFENPRODIL; JOROTOXIN; KAINIC ACID; NEUROTOXIN; NEUROTOXIN SRTX1.3; NIPECOTIC ACID; OMEGA AGATOXIN; OMEGA AGATOXIN IVA; OMEGA CONOTOXIN MVIIA; PEPTIDE DERIVATIVE; PHILANTHOTOXIN 343; PICROTOXIN; PILOCARPINE; POLYAMINE; TSTX TOXIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VENOM;

ANTICONVULSANT ACTIVITY; CHRONIC DISEASE; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG TOLERABILITY; EPILEPSY; HUMAN; INTRACTABLE PAIN; INVERTEBRATE; NEUROPATHIC PAIN; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; SCORPION; SEIZURE; SNAIL; SPIDER; SYNAPTIC TRANSMISSION; SYSTEMATIC REVIEW; WASP;

ANIMALS; ANTICONVULSANTS; DRUG DESIGN; EPILEPSY; HUMANS; INVERTEBRATES; NEUROTOXINS; PEPTIDES; POLYAMINES; VENOMS;

EID: 34147178918     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.01.009     Document Type: Review

References (142)

1. Abe T., Kawai N., and Miwa A. Effects of a spider toxin on the glutamatergic synapse of lobster muscle. J Physiol 339 (1983) 243-252
2. Andersen K.E., Lau J., Lundt B.F., Petersen H., Huusfeldt P.O., Suzdak P.D., et al. Synthesis of novel GABA uptake inhibitors: Part 6. Preparation and evaluation of N-omega asymmetrically substituted nipecotic acid derivatives. Bioorg Med Chem 9 11 (2001) 2773-2785
3. Ängehagen M., Ben-Menachem E., Ronnback L., and Hansson E. Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate. Neurochem Res 28 2 (2003) 333-340
4. Aramaki Y., Yasuhara T., Shimazaki K., Kawai N., and Nakajima T. Chemical structure of joro spider toxin (JSTX). Biomed Res 8 4 (1987) 241-245
5. Armishaw C.J., and Alewood P.F. Conotoxins as research tools and drug leads. Curr Protein Pept Sci 6 (2005) 221-240
6. Armstrong H., Zhou L., Layer R., Nielson J., McCabe R.T., and White H.S. Anticonvulsant profile of conantokin-G: a novel, broad-spectrum NMDA antagonist. Epilepsia 39 S6 (1998) 39
7. Barchi R.L. Ion channel mutations affecting muscle and brain. Curr Opin Neurol 11 (1998) 461-468
8. Barton M.E., and White H.S. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression. Epilepsy Res 59 (2004) 1-12
9. Barton M.E., White H.S., and Wilcox K.S. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs. Epilepsy Res 59 (2004) 13-24
10. Beleboni R.O., Pizzo A.B., Fontana A.C.K., Carolino R.O.G., Coutinho-Netto J., and Santos W.F. Spider and wasp neurotoxins: pharmacological and biochemical aspects. Eur J Pharmacol 493 (2004) 1-17
11. Beleboni R.O., Carolino R.O., Pizzo A.B., Castellan-Baldan L., Coutinho-Netto J., Santos W.F., et al. Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships. Cell Mol Neurobiol 24 (2004) 707-728
12. Beleboni R.O., Guizzo R., Fontana A.C.K., Pizzo A.B., Carolino R.O.G., Gobbo-Neto L., et al. Neurochemical characterization of a neuroprotective compound from Parawixia bistriata spider venom that inhibits synaptosomal uptake of GABA and glycine. Mol Pharmacol 69 6 (2006) 1998-2006
13. Bergin A.M., and Connolly M. New antiepileptic drug therapies. Neurol Clin 20 (2002) 1163-1182
14. Bialer M., Jonhannessen S.I., Kupferber H.I., Levy R.H., Loiseau E., and Perucca E. Progress report on new antiepileptic drugs: a summary of the sixth Eilat conference (EILAT VI). Epilepsy Res 51 (2002) 31-71
15. Blackburn-Munro G., Bomholt S.F., and Erichsen H.K. Behavioral effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain. Neuropharmacology 47 (2004) 351-362
16. Blagbrough I.S., Moya E., and Taylor S. Polyamines and polyamine amides from wasps and spiders. Biochem Soc Trans 22 4 (1994) 888-893
17. Blum D.E. New drugs for persons with epilepsy. Adv Neurol 76 (1998) 57-81
18. Böhme I., and Luddens H. The inhibitory neural circuitry as target of antiepileptic drugs. Curr Med Chem 8 11 (2001) 1257-1274
19. Brines M.L., Sundaresan S., Spencer D.D., and de Lanerolle N.C. Quantitative autoradiographic analysis of ionotropic glutamate receptor subtypes in human temporal lobe epilepsy: up-regulation in reorganized epileptogenic hippocampus. Eur J Neurosci 9 (1997) 2035-2044
20. Cairrão M.A.R., Ribeiro A.M., Pizzo A.B., Fontana A.C.K., Beleboni R.O., Coutinho-Neto J., et al. Anticonvulsant and GABA uptake inhibition properties of P. bistriata and S. raptoria spider venom fractions. Pharm Biol 40 (2002) 472-477
21. Calabresi P., Centonze D., Pisani A., Cupini L., and Bernardi G. Synaptic plasticity in the ischaemic brain. Lancet Neurol 2 10 (2003) 622-629
22. Carvalho F.F., Nencioni A.L., Lebrun I., Sandoval M.R., and Dorce V.A. Behavioral, electroencephalographic, and histopathologic effects of a neuropeptide isolated from Tityus serrulatus scorpion venom in rats. Pharmacol Biochem Behav 60 (1998) 7-14
23. Cohen L., Lipstein N., and Gordon D. Allosteric interactions between scorpion toxin receptor sites on voltage-gated Na channels imply a novel role for weakly active components in arthropod venom. FASEB J 20 11 (2006) 1933-1935
24. Colledge C.J., Hunsperger J.P., Imperial J.S., and Hillyard D.R. Precursor structure of omega-conotoxin GVIA determined from a cDNA clone. Toxicon 30 (1992) 1111-1116
25. Corona M., Coronas F.V., Merino E., Becerril B., Gutiérrez R., Rebolledo-Antunez S., et al. A novel class of peptide found in scorpion venom with neurodepressant effects in peripheral and central nervous system of the rat. Biochim Bioohys Acta 1649 (2003) 58-67
26. Cunha A.O., Mortari M.R., Oliveira L., Carolino R.O., Coutinho-Netto J., and Santos W.F. Anticonvulsant effects of the wasp Polybia ignobilis venom on chemically induced seizures and action on GABA and glutamate receptors. Comp Biochem Physiol C Toxicol Pharmacol 141 (2005) 50-57
27. Czapinski P., Blaszczyk B., and Czuczwar S.J. Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 5 1 (2005) 3-14
28. Dalby N.O. GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors. Neuropharmacology 39 12 (2000) 2399-2407
29. De Deyn P.P., D'Hooge R., Marescau B., and Pei Y.Q. Chemical models of epilepsy with some reference to their aplicability in the development of aniconvulsants. Epilepsy Res 12 (1992) 87-110
30. de Figueiredo S.G., de Lima M.E., Nascimento Cordeiro M., Diniz C.R., Patten D., Halliwell R.F., et al. Purification and amino acid sequence of a highly insecticidal toxin from the venom of the brazilian spider Phoneutria nigriventer which inhibits NMDA-evoked currents in rat hippocampal neurones. Toxicon 39 2--3 (2001) 309-317
31. de Silva M., MacArdle B., McGowan M., Huges E., Stewart J., Neville B.G., et al. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 347 (1996) 709-713
32. Dichter M.A. Mechanisms of action of new antiepileptic drugs. Adv Neurol 76 (1998) 1-9
33. Dodd P.R., Watson W.E., Morrison M.M., Johnston G.A., Bird E.D., Cowburn R.F., et al. Uptake of gamma-aminobutyric acid and l-glutamic acid by synaptosomes from postmortem human cerebral cortex: multiple sites, sodium dependence and effect of tissue preparation. Brain Res 490 2 (1989) 320-331
34. Eldefrawi A.T., Eldefrawi M.E., Konno K., Mansour N.A., Nakanishi K., Oltz E., et al. Structure and synthesis of a potent glutamate receptor antagonist in wasp venom. Proc Natl Acad Sci 85 13 (1988) 4910-4913
35. Filmer R.M. A Catalogue of Nomenclature and Taxonomy in the Living, Conidae 1758-1998 (2001), Backhuys Publisher, Leiden, The Netherlands
36. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J Neurochem 42 (1984) 1-11
37. Fontana A.C., Guizzo R., de Oliveira B.R., Meirelles e Silvam A.R., Coimbra N.C., Amara S.G., et al. Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake. Br J Pharmacol 139 7 (2003) 1297-1309
38. Gelfuso E.A., Cunha A.O.S., Mortari M.R., Liberato J.L., Paraventi K.H., Beleboni R.O., et al. Neuropharmacological profile of FrPbAII, purified from the venom of the social spider Parawixia bistriata (Araneae, Araneidae), in Wistar rats. Life Sciences 80 6 (2007) 566-572
39. Green A.C., Nakanishi K., and Usherwood P.N.R. Polyamine amides are neuroprotective in cerebellar granulle cell cultures challenged with excitatory amino acids. Brain Res 717 (1996) 135-146
40. Grishin E.V., Volkova T.M., Arseniev A.S., Reshetova O.S., Onoprienko V.V., Magazanic L.G., et al. Structure-functional characterization of argiopine- an ion channel blocker from the venom of spider Argiope lobata. Bioorg Khim 12 (1986) 1121-1124
41. Guerrini R. Epilepsy in children. Lancet 367 (2006) 499-524
42. Himi T., Saito H., Kawai N., and Nakajima T. Spider toxin (JSTX-3) inhibits the convulsions induced by glutamate agonists. J Neural Transm Gen Sect 80 2 (1990) 95-104
43. Inceoglu B., Lango J., Pessah I.N., and Hammock B.D. Three structurally related, highly potent, peptides from the venom of Parabuthus transvaalicus possess divergent biological activity. Toxicon 45 6 (2005) 727-733
44. Iversen L. GABA pharmacology-what prospects for the future?. Biochem Pharmacol 68 8 (2004) 1537-1540
45. Jackson H., and Parks T.N. Anticonvulsivant action of an arylamine-containing fraction from Agelenopsis spider venom. Brain Res 526 2 (1990) 338-341
46. ++ channel toxins in DBA/2 mice. Psychopharmacology 126 1 (1996) 85-90
47. Jackson H., and Usherwood P.N.R. Spider toxins as tools for dissecting elements of excitatory amino acid transmission. Tins 11 (1988) 278-283
48. Jallon P. Epilepsy in developing countries. Epilepsia 38 10 (1997) 1143-1151
49. Ji Y.H., Mansuelle P., Terakawa S., Kopeyan C., Yanaihara N., Hsu K., et al. Two neurotoxins (BmK I and BmK II) from the venom of the scorpion Buthus martensi Karsch: purification, amino acid sequences and assessment of specific activity. Toxicon 34 9 (1996) 987-1001
50. Jimenez E.C., Donevan S., Walker C., Zhou L.M., Nielsen J., Cruz L.J., et al. Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency. Epilepsy Res 51 1--2 (2002) 73-80
51. Jones R.M., and Bulaj G. Conotoxins-new vistas for peptide therapeutics. Curr Pharm Des 6 12 (2000) 1249-1285
52. Jones M.G., and Lodge D. Comparison of some arthropod toxins and toxin fragments as antagonists of excitatory amino acid-induced excitation of rat spinal neurones. Eur J Pharmacol 204 2 (1991) 203-209
53. Jones M.G., Anis N.A., and Lodge D. Philanthotoxin blocks quisqualate-, AMPA- and kainate-, but not NMDA-, induced excitation of rat brainstem neurones in vivo. Br J Pharmacol 101 4 (1990) 968-970
54. Kanai H., Ishida N., Nakajima T., and Kato N. An analogue of Joro spider toxin selectively suppresses hippocampal epileptic discharges induced by quisqualate. Brain Res 581 1 (1992) 161-164
55. ++-currents in rat hippocampal CA1 neurones. Eur J Pharmacol 270 (1994) 357-360
56. Kawai N., and Nakajima T. Neurotoxins from spider venoms. In: Harvey A.L. (Ed). Natural and Synthetic Neurotoxins (1993), Acad. Press, London 319-345
57. Kawai N., Niwa A., and Abe T. Spider venom contains specific receptor blocker of glutaminergic synapses. Brain Res 247 1 (1982) 169-171
58. Kawai N., Miwa A., and Abe T. Specific antagonism of the glutamate receptor by an extract from the venom of the spider Araneus ventricosus. Toxicon 21 3 (1983) 438-440
59. Klein R.C., and Castellino F.J. Inhibition of MK801 binding in adult rat brain sections by conantokin-G and conantokin-T. Neurosci Lett 273 3 (1999) 171-174
60. Kohl B.K., and Dannhardt G. The NMDA receptor complex: a promising target for novel antiepileptic strategies. Curr Med Chem 8 11 (2001) 1275-1289
61. Kwan P., Sills G.J., and Brodie M.J. The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther 90 1 (2001) 21-34
62. LaRoche S.M., and Helmers S.L. The new antiepileptic drugs: scientific review. JAMA 291 5 (2004) 605-614
63. LaRoche S.M., and Helmers S.L. The new antiepileptic drugs: clinical applications. JAMA 291 5 (2004) 615-620
64. Liberato J.L., Cunha A.O., Mortari M.R., Gelfuso E.A., de Oliveira B.R., Coutinho-Netto J., et al. Anticonvulsant and anxiolytic activity of FrPbAII, a novel GABA uptake inhibitor isolated from the venom of the social spider Parawixia bistriata (Araneidae: Araneae). Brain Res 1124 1 (2006) 19-27
65. Löscher W. New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342 (1998) 1-13
66. MacDonald R.L., and Kelly K.M. Antiepileptic drug mechanisms of action. Epilepsia 36 Suppl 2 (1995) S2-S12
67. Mafra R.A., Figueiredo S.G., Diniz C.R., Cordeiro M.N., Cruz J.D., and De Lima M.E. PhTx4, a new class of toxins from Phoneutria nigriventer spider venom, inhibits the glutamate uptake in rat brain synaptosomes. Brain Res 831 1--2 (1999) 297-300
68. McCormick K.D., and Meinwald J. Neurotoxic acylpolyamines from spider venoms. J Chem Ecol 19 (1993) 2411-2451
69. McIntosh J.M., and Jones R.M. Cone venom-from accidental stings to deliberate injection. Toxicon 39 10 (2001) 1447-1451
70. McIntosh J.M., Olivera B.M., Cruz L.J., and Gray W.R. Gamma-carboxyglutamate in a neuroactive toxin. J Biol Chem 259 23 (1984) 14343-14346
71. Meldrum B.S. The role of glutamate in epilepsy and other CNS disorders. Neurology 44 11 Suppl 8 (1994) S14-S23
72. Meldrum B.S. Action of established and novel anticonvulsant drugs on the basic mechanisms of epilepsy. Epilepsy Res 11 (1996) 67-77
73. Meldrum B.S. Identification and preclinical testing of novel antiepileptic compounds. Epilepsia 38 Suppl. 9 (1997) S7-S15
74. Meldrum H., and Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11 (1990) 379-387
75. Meldrum B.S., Akbar M.T., and Chapman A.G. Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res 36 2-3 (1999) 189-204
76. Mellor I.R., and Usherwood P.N.R. Targeting ionotropic receptors with polyamine-containing toxins. Toxicon 43 (2004) 493-508
77. Mellor I.R., Brier T.J., Pluteanu F., Stromgaard K., Saghyan A., Eldursi N., et al. Modification of the philanthotoxin-343 polyamine moiety results in different structure-activity profiles at muscle nicotinic ACh, NMDA and AMPA receptors. Neuropharmacology 44 1 (2003) 70-80
78. Miljanich G.P. Venom peptides as human pharmaceuticals. Sci Med 4 5 (1997) 6-15
79. Mintz I.M., Venema V.J., Swiderek K.M., Lee T.D., Bean B.P., and Adams M.E. P-type calcium channels blocked by the spider toxin omega-Aga-IVA. Nature 355 6363 (1992) 827-829
80. Moller C., Rahmankhah S., Lauer-Fields J., Bubis J., Fields G.B., and Mari F. A novel conotoxin framework with a helix-loop-helix (Cs alpha/alpha) fold. Biochemistry 44 49 (2005) 15986-15996
81. Mortari M.R., Cunha A.O.S., de Oliveira L., Vieira E.B., Gelfuso E.A., Coutinho-Netto J., et al. Anticonvulsant and behavioural effects of the denatured venom of the social wasp Polybia occidentalis (Polistinae, Vespidae). Basic Clin Pharmacol Toxicol 97 5 (2005) 289-295
82. Mueller A.L., Artman L.D., Balandrin M.F., Brady E., Chien Y., Delmar E.G., et al. NPS 1506, a novel NMDA receptor antagonist and neuroprotectant. Review of preclinical and clinical studies. Ann NY Acad Sci 890 (1999) 450-457
83. Mueller A.L., Artman L.D., Balandrin M.F., Brady E., Chien Y., DelMar E.G., et al. NPS 1506, a moderate affinity uncompetitive NMDA receptor antagonist: preclinical summary and clinical experience. Amino Acids 19 1 (2000) 177-179
84. Mussi-Ribeiro A., Miranda A., Gobbo-Neto L., Peporine L.N., and Santos W.F. A anticonvulsive fraction from Scaptocosa raptoria (Araneae: Lycosidae) spider venom. Neurosci Lett 371 2--3 (2004) 171-175
85. Nelson L. Venomous snails: one slip, and you're dead.... Nature 429 6994 (2004) 798-799
86. Nencioni A.L., Lebrun I., and Dorce V.A. A microdialysis study of glutamate concentration in the hippocampus of rats after TsTX toxin injection and blockade of toxin effects by glutamate receptor antagonists. Pharmacol Biochem Behav 74 2 (2003) 455-463
87. Nihei K., Kato M.J., Yamane T., Palma M.S., and Konno K. An efficient and versatile synthesis of acylpolyamine spider toxins. Bioorg Med Chem Lett 12 3 (2002) 299-302
88. Norton R.S., and Olivera B.M. Conotoxins down under. Toxicon 48 7 (2006) 780-798
89. Olivera B.M. Conus venom peptides, receptor and ion channel targets, and drug design: 50 million years of neuropharmacology. Mol Biol Cell 8 11 (1997) 2101-2109
90. Olivera B.M., Gray W.R., Zeikus R., McIntosh J.M., Varga J., Rivier J., et al. Peptide neurotoxins from fish-hunting cone snails. Science 230 4732 (1985) 1338-1343
91. Olivera B.M., Miljanich G.P., Ramachandran J., and Adams M.E. Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins. Annu Rev Biochem 63 (1994) 823-867
92. Olivera B.M., Cruz L.J., and Yoshikami D. Effects of Conus peptides on the behavior of mice. Curr Opin Neurobiol 9 6 (1999) 772-777
93. Oliveira L.C., De Lima M.E., Pimenta A.M., Mansuelle P., Rochat H., Cordeiro M.N., et al. PnTx4-3, a new insect toxin from Phoneutria nigriventer venom elicits the glutamate uptake inhibition exhibited by PhTx4 toxic fraction. Toxicon 42 7 (2003) 793-800
94. Oliveira L., Cunha A.O.S., Mortari M.R., Pizzo A.B., Miranda A., Coimbra N.C., et al. Effects of microinjections of neurotoxin AvTx8, isolated from the social wasp Agelaia vicina (Hymenoptera; Vespidae) venom, on GABAergic nigrotectal pathways. Brain Res 1031 1 (2005) 74-81
95. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., and Sesma M.A. NMDA antagonist neurotoxicity: mechanism and prevention. Science 254 (1991) 1515-1518
96. Olsen R.W., and Avoli M. GABA and epileptogenesis. Epilepsia 38 4 (1997) 399-407
97. Osborne N.N., Chidlow G., Layton C.J., Wood J.P., Casson R.J., and Melena J. Optic nerve and neuroprotection strategies. Eye 18 11 (2004) 1075-1084
98. Painter M.J., Scher M.S., Stein A.D., Armatti S., Wang Z., Gardiner J.C., et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 341 (1999) 485-489
99. Piek T. 6-Philanthotoxin, a semi-irreversible blocker of ion channels. Comp Biochem Physiol 72 (1982) 311-315
100. Pinheiro A.C., Gómez R.S., Massensini A.R., Cordeiro M.N., Richardson M., Romano-Silva M.A., Prado M.A., De Marco L., and Gómez M.V. Neuroprotective effect on brain injury by neurotoxins from the spider Phoneutria nigriventer. Neurochem Int 49 5 (2006) 543-547
101. Pizzo A.B., Fontana A.C.K., Coutinho-Netto J., and Santos W.F. Effects of the crude venom of the social wasp Agelaia vicina on g-aminobutyric acid and glutamate uptake in synaptosomes from rat cerebral cortex. J Biochem Mol Toxicol 14 2 (2000) 88-94
102. Pizzo A.B., Beleboni R.O., Fontana A.C.K., Ribeiro A.M., Miranda A., Coutinho-Netto J., et al. Characterization of the actions of AvTx7 isolated from Agelaia vicina (Hymenoptera: Vespidae) wasp venom on synaptosomal glutamate uptake and release. J Biochem Mol Toxicol 18 2 (2004) 61-68
103. Porter R.J., and Rogawski M.A. Theoretical and practical considerations concerning the use of NMDA antagonists in the treatment of the epilepsies. Clin Neuropharmacol 15 Suppl 1 Pt A (1992) 697A-698A
104. +-channels. Eur J Biochem 264 2 (1999) 287-300
105. Possani L.D., Merino E., Corona M., Bolivar F., and Becerril B. Peptides and genes coding for scorpion toxins that affect ion-channels. Biochimie 82 9--10 (2000) 861-868
106. Prado M.A., Guatimosim C., Gómez M.V., Diniz C.R., Cordeiro M.N., and Romano-Silva M.A. A novel tool for the investigation of glutamate release from rat cerebrocortical synaptosomes: the toxin Tx3-3 from the venom of the spider Phoneutria nigriventer. Biochem J 314 1 (1996) 145-150
107. Proper E.A., Hoogland G., Kappen S.M., Jansen G.H., Rensen M.G., Schrama L.H., et al. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125 Pt 1 (2002) 32-43
108. Rash L.D., and Hodgson W.C. Pharmacology and biochemistry of spider venoms. Toxicon 40 3 (2002) 225-254
109. Raza M., Shaheen F., Choudhary M.I., Sombati S., Rafiq A., Suria A., et al. Anticonvulsant activities of ethanolic extract and aqueous fraction isolated from Delphinium denudatum. J Ethonopharmacol 78 (2001) 73-78
110. Reis H.J., Prado M.A., Kalapothakis E., Cordeiro M.N., Diniz C.R., De Marco L.A., et al. Inhibition of glutamate uptake by a polypeptide toxin (phoneutriatoxin 3-4) from the spider Phoneutria nigriventer. Biochem J 343 2 (1999) 413-418
111. Rochat H., Bernard P., and Couraud F. Scorpion toxins: chemistry and mode of action. Adv Cytopharmacol 3 (1979) 325-334
112. Rogawski M.A. Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res 69 3 (2006) 273-294
113. Rogawski M.A., and Donevan S.D. AMPA receptors in epilepsy and as targets for antiepileptic drugs. Adv Neurol 79 (1999) 947-963
114. Rogoza L.N., Salakhutdinov N.F., and Tolstikov G.A. Polymethyleneamine alkaloids of animal origin: II. Polyamine neurotoxins. Russ J Bioorgan Chem 32 1 (2006) 27-41
115. Sandoval M.R., and Lebrun I. TsTx toxin isolated from Tityus serrulatus scorpion venom-induced spontaneous recurrent seizures and mossy fiber sprouting. Epilepsia 43 7 (2003) 904-911
116. Sattler R., and Tymianski M. Molecular mechanisms of calcium-dependent excitotoxicity. J Mol Med 78 1 (2000) 3-13
117. Shen G.S., Layer R.T., and McCabe R.T. Conopeptides: from deadly venoms to novel therapeutics. Drug Discov Today 5 (2000) 98-106
118. Spanjer W., May T.E., Piek T., and De Hann N. Partial purification of components from the paralysing venom of the digger wasp Philanthus triangulum and their action on neuromuscular transmission in the locust. Comp Biochem Physiol 71 (1982) 149-157
119. Stefan H., and Feuerstein T.J. Novel anticonvulsant drugs. Pharmacol Ther 113 1 (2007) 165-183
120. Stefani A., Spadoni F., and Bernardi G. Voltage-activated calcium channels: targets of antiepileptic drug therapy?. Epilepsia 38 9 (1997) 959-965
121. Stromgaard K. Natural products as tools for studies of ligand-gated ion channels. Chem Rec 5 4 (2005) 229-239
122. Stromgaard K., and Mellor I. AMPA receptor ligands: synthetic and pharmacological studies of polyamines and polyamine toxins. Med Res Rev 24 5 (2004) 589-620
123. Stromgaard K., Andersen K., Krogsgaard-Larsen P., and Jaroszewski J.W. Recent advances in the medicinal chemistry of polyamine toxins. Mini Rev Med Chem 1 4 (2001) 317-338
124. Stromgaard K., Jensen L.S., and Vogensen S.B. Polyamine toxins: development of selective ligands for ionotropic receptors. Toxicon 45 3 (2005) 249-254
125. Takazawa A., Yamazaki O., Kanai H., Ishida N., Kato N., and Yamauchi T. Potent and long-lasting anticonvulsant effects of 1-naphthylacetyl spermine, an analogue of Joro spider toxin, against amygdaloid kindled seizures in rats. Brain Res 706 1 (1996) 173-176
126. Tammaro P., Conti F., and Moran O. Modulation of sodium current in mammalian cells by an epilepsy-correlated beta 1-subunit mutation. Biochem Biophys Res Commun 291 4 (2002) 1095-1101
127. Tang F., Yue S., Luo Z., Feng D., Wang M., Qian C., et al. Role of N-methyl-d-aspartate receptor in hyperoxia-induced lung injury. Pediatr Pulmonol 40 5 (2005) 437-444
128. Terlau H., and Olivera B.M. Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol Rev 84 (2004) 41-68
129. Tunnicliff G. Basis of the antiseizure action of phenytoin. Gen Pharmacol 27 (1996) 1091-1097
130. Uchitel O.D. Toxins affecting calcium channels in neurons. Toxicon 35 (1997) 1161-1191
131. Usherwood P.N.R., and Blagbrough I.S. Spider toxins affecting glutamate receptors: polyamines in therapeutic neurochemistry. Pharmacol Ther 52 (1991) 245-268
132. Verity C.M., Hosking G., and Easter D.J. A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The paeditric EPITEG collaborative group. Dev Med Child Neurol 37 (1995) 97-108
133. Villetti G., Bregola G., Bassani F., Bergamaschi M., Rondelli I., Pietra C., et al. Preclinical avaliation of CHF3381 as a novel antiepileptic agent. Neuropharmacology 40 (2001) 866-878
134. Wang C.Z., and Chi C.W. Conus peptides-a rich pharmaceutical treasure. Acta Biochim Biophys 36 11 (2004) 713-723
135. Wang C.G., He X.L., Shao F., Liu W., Ling M.H., Wang D.C., et al. Molecular characterization of an anti-epilepsy peptide from the scorpion Buthus martensi Karsch. Eur J Biochem 268 (2001) 2480-2485
136. Watkins J.C. l-Glutamate as a central neurotransmitter: looking back. Biochem Soc Trans 28 4 (2000) 297-309
137. White H.S., McCabe R.T., Armstrong H., Donevan S.D., Cruz L.J., Abogadie F.C., et al. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. J Pharmacol Exp Ther 292 1 (2000) 425-432
138. Wittekindt B., Malany S., Schemm R., Otvos L., Maccecchini M.L., Laube B., et al. Point mutations identify the glutamate binding pocket of the N-methyl-d-aspartate receptor as major site of conantokin-G inhibition. Neuropharmacology 41 6 (2001) 753-761
139. Woodward S.R., Cruz L.J., Olivera B.M., and Hillyard D.R. Constant and hypervariable regions in conotoxin propeptides. EMBO J 9 4 (1990) 1015-1020
140. Xiong Y.M., Lan Z.D., Wang M., Liu B., Liu X.Q., Fei H., et al. Molecular characterization of a new excitatory insect neurotoxin with an analgesic effect on mice from the scorpion Buthus martensi Karsch. Toxicon 37 8 (1999) 1165-1180
141. Yamashita H., Ohno K., Amada Y., Hattori H., Ozawa-Funatsu Y., Toya T., et al. Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats. J Pharmacol Exp Ther 308 1 (2004) 127-133
142. Zhou X.H., Yang D., Zhang J.H., Liu C.M., and Lei K.J. Purification and N-terminal partial sequence of anti-epilepsy peptide from venom of the scorpion Buthus martensii Karsch. Biochem J 257 2 (1989) 509-517